Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alexza Pharmaceuticals, Inc.
Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
April 19th, 2008
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced that it has obtained a committed equity financing facility under which it may sell up to $50 million of its registered common stock to Azimuth Opportunity, Ltd. over a 24-month period. Alexza is not obligated to utilize any of the $50 million facility and remains free to enter into and consummate other equity and debt financing transactions. "This flexible financing facility is an important addition to our portfolio of financing options, giving us the ability to raise capital quickly and at a competitive cost, and potentially to manage dilution more effectively by issuing shares in multiple tranches at times of our...
Source: Law & Health Weekly (2008-04-19)
|
